TWI453401B - 使用時間解析電流測定法之用於分析物濃度測定的系統及方法（一） - Google Patents
使用時間解析電流測定法之用於分析物濃度測定的系統及方法（一） Download PDFInfo
- Publication number
- TWI453401B TWI453401B TW097128393A TW97128393A TWI453401B TW I453401 B TWI453401 B TW I453401B TW 097128393 A TW097128393 A TW 097128393A TW 97128393 A TW97128393 A TW 97128393A TW I453401 B TWI453401 B TW I453401B
- Authority
- TW
- Taiwan
- Prior art keywords
- current
- time segment
- analyte concentration
- target range
- time
- Prior art date
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 142
- 238000000034 method Methods 0.000 title claims abstract description 75
- 238000004082 amperometric method Methods 0.000 title description 3
- 238000011088 calibration curve Methods 0.000 claims abstract description 82
- 239000012530 fluid Substances 0.000 claims abstract description 43
- 230000005284 excitation Effects 0.000 claims abstract description 39
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 229940088598 enzyme Drugs 0.000 claims description 9
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims description 6
- 235000010299 hexamethylene tetramine Nutrition 0.000 claims description 6
- 239000004312 hexamethylene tetramine Substances 0.000 claims description 6
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 claims description 6
- 108010015776 Glucose oxidase Proteins 0.000 claims description 5
- 239000004366 Glucose oxidase Substances 0.000 claims description 5
- 229940116332 glucose oxidase Drugs 0.000 claims description 5
- 235000019420 glucose oxidase Nutrition 0.000 claims description 5
- -1 potassium ferricyanide Chemical compound 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims 1
- 238000012360 testing method Methods 0.000 description 123
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 56
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 55
- 239000008103 glucose Substances 0.000 description 55
- 210000004369 blood Anatomy 0.000 description 41
- 239000008280 blood Substances 0.000 description 41
- 239000010410 layer Substances 0.000 description 39
- 238000012937 correction Methods 0.000 description 37
- 238000005259 measurement Methods 0.000 description 32
- 238000005534 hematocrit Methods 0.000 description 23
- 239000003153 chemical reaction reagent Substances 0.000 description 17
- 238000001514 detection method Methods 0.000 description 17
- 239000000243 solution Substances 0.000 description 15
- 239000000306 component Substances 0.000 description 13
- 210000000601 blood cell Anatomy 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 125000006850 spacer group Chemical group 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000005070 sampling Methods 0.000 description 6
- 239000012086 standard solution Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 239000004020 conductor Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000012790 adhesive layer Substances 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000002405 diagnostic procedure Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000012503 blood component Substances 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000012777 electrically insulating material Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 230000001960 triggered effect Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000000840 electrochemical analysis Methods 0.000 description 2
- 238000013213 extrapolation Methods 0.000 description 2
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 230000027756 respiratory electron transport chain Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000011218 segmentation Effects 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- NECRQCBKTGZNMH-UHFFFAOYSA-N 3,5-dimethylhex-1-yn-3-ol Chemical compound CC(C)CC(C)(O)C#C NECRQCBKTGZNMH-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000016222 Pancreatic disease Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 239000012992 electron transfer agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 238000009532 heart rate measurement Methods 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000000138 intercalating agent Substances 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3273—Devices therefor, e.g. test element readers, circuitry
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95207607P | 2007-07-26 | 2007-07-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200914820A TW200914820A (en) | 2009-04-01 |
| TWI453401B true TWI453401B (zh) | 2014-09-21 |
Family
ID=39951498
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW097128393A TWI453401B (zh) | 2007-07-26 | 2008-07-25 | 使用時間解析電流測定法之用於分析物濃度測定的系統及方法（一） |
| TW097128397A TW200916774A (en) | 2007-07-26 | 2008-07-25 | System and methods for determination of analyte concentration using time resolved amperometry |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW097128397A TW200916774A (en) | 2007-07-26 | 2008-07-25 | System and methods for determination of analyte concentration using time resolved amperometry |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20090076738A1 (OSRAM) |
| EP (2) | EP2176653B1 (OSRAM) |
| JP (2) | JP5179583B2 (OSRAM) |
| AT (1) | ATE523777T1 (OSRAM) |
| AU (2) | AU2008279070B2 (OSRAM) |
| BR (2) | BRPI0814201A2 (OSRAM) |
| MX (3) | MX2010000971A (OSRAM) |
| TW (2) | TWI453401B (OSRAM) |
| WO (2) | WO2009015316A1 (OSRAM) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2553632A1 (en) | 2004-02-06 | 2005-08-25 | Bayer Healthcare Llc | Oxidizable species as an internal reference for biosensors and method of use |
| EP3483598B1 (en) | 2005-09-30 | 2024-11-06 | Ascensia Diabetes Care Holdings AG | Gated voltammetry |
| TWI453401B (zh) * | 2007-07-26 | 2014-09-21 | Nipro Diagnostics Inc | 使用時間解析電流測定法之用於分析物濃度測定的系統及方法（一） |
| US8101062B2 (en) * | 2007-07-26 | 2012-01-24 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
| EP2222867B1 (en) * | 2007-12-10 | 2018-07-11 | Ascensia Diabetes Care Holdings AG | Rapid-read gated amperometry |
| WO2009076302A1 (en) | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Control markers for auto-detection of control solution and methods of use |
| JP2009272996A (ja) * | 2008-05-09 | 2009-11-19 | Toshiba Corp | 携帯端末 |
| US8262899B2 (en) | 2008-07-10 | 2012-09-11 | Bayer Healthcare Llc | Systems and methods including amperometric and voltammetric duty cycles |
| ATE546730T1 (de) * | 2008-11-26 | 2012-03-15 | Atotech Deutschland Gmbh | Verfahren zur kontrolle von stabilisatoradditiven in elektrolyten zur chemischen metall- und metalllegierungsabscheidung |
| JP2010261895A (ja) * | 2009-05-11 | 2010-11-18 | Emiko Kaneko | 溶液中微量成分の濃度測定方法及び濃度測定装置 |
| US8173008B2 (en) * | 2009-06-24 | 2012-05-08 | Lifescan, Inc. | Method for determining an analyte in a bodily fluid sample using an analyte test strip with combination electrode contact and meter identification feature |
| US20100326824A1 (en) * | 2009-06-24 | 2010-12-30 | Lifescan, Inc. | Analyte test strip with combination electrode contact and meter identification feature |
| US8877034B2 (en) * | 2009-12-30 | 2014-11-04 | Lifescan, Inc. | Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity |
| US8101065B2 (en) | 2009-12-30 | 2012-01-24 | Lifescan, Inc. | Systems, devices, and methods for improving accuracy of biosensors using fill time |
| KR101929057B1 (ko) * | 2010-03-22 | 2018-12-13 | 바이엘 헬쓰케어 엘엘씨 | 바이오센서를 위한 잔여 보상 |
| EP2565636A3 (en) * | 2010-03-31 | 2013-04-03 | Lifescan Scotland Limited | Electrochemical analyte measurement method and system |
| WO2012035297A1 (en) * | 2010-09-13 | 2012-03-22 | Lifescan Scotland Limited | Analyte measurement method and system with hematocrit compensation |
| US8932445B2 (en) | 2010-09-30 | 2015-01-13 | Cilag Gmbh International | Systems and methods for improved stability of electrochemical sensors |
| US8617370B2 (en) | 2010-09-30 | 2013-12-31 | Cilag Gmbh International | Systems and methods of discriminating between a control sample and a test fluid using capacitance |
| WO2012084194A1 (en) | 2010-12-22 | 2012-06-28 | Roche Diagnostics Gmbh | Systems and methods to compensate for sources of error during electrochemical testing |
| WO2012142536A2 (en) * | 2011-04-14 | 2012-10-18 | Bayer Healthcare Llc | Detection of contamination at sensor contacts |
| US9775806B2 (en) | 2011-09-21 | 2017-10-03 | Ascensia Diabetes Care Holdings Ag | Analysis compensation including segmented signals |
| US8534115B2 (en) * | 2011-10-17 | 2013-09-17 | Schlumberger Technology Corporation | Systems and methods of determining parameter values in a downhole environment |
| US9636044B2 (en) * | 2012-02-01 | 2017-05-02 | Invoy Technologies, Llc | Breath analyzer with expandable range of measurement |
| WO2014100428A1 (en) * | 2012-12-20 | 2014-06-26 | Becton, Dickinson And Company | System and method for using multiple sensor calibration methods |
| GB201511299D0 (en) * | 2015-06-26 | 2015-08-12 | Inside Biometrics Ltd | Test device and method of using a test device |
| WO2019036586A1 (en) * | 2017-08-18 | 2019-02-21 | Diversey, Inc. | Solution concentration sensing devices |
| CN111683592B (zh) * | 2017-10-30 | 2023-11-03 | 加利福尼亚大学董事会 | 使用电化学传感器对分析物进行无校正的体内测量 |
| US20240389890A1 (en) * | 2021-09-27 | 2024-11-28 | Medtrum Technologies Inc. | Analyte detection system |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6424847B1 (en) * | 1999-02-25 | 2002-07-23 | Medtronic Minimed, Inc. | Glucose monitor calibration methods |
| TW520439B (en) * | 2000-02-02 | 2003-02-11 | Lifescan Inc | Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations |
| US20030096420A1 (en) * | 2001-11-07 | 2003-05-22 | Heller Zindel Herbert | Instrument |
| CN1311233C (zh) * | 2001-10-26 | 2007-04-18 | 爱科来株式会社 | 特定成份的浓度测定方法和浓度测定装置 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6279159U (OSRAM) * | 1985-11-07 | 1987-05-20 | ||
| JPH0672845B2 (ja) * | 1986-09-01 | 1994-09-14 | 富士写真フイルム株式会社 | 分析方法 |
| US5352351A (en) * | 1993-06-08 | 1994-10-04 | Boehringer Mannheim Corporation | Biosensing meter with fail/safe procedures to prevent erroneous indications |
| US6153069A (en) * | 1995-02-09 | 2000-11-28 | Tall Oak Ventures | Apparatus for amperometric Diagnostic analysis |
| AUPN661995A0 (en) * | 1995-11-16 | 1995-12-07 | Memtec America Corporation | Electrochemical cell 2 |
| JPH09292387A (ja) * | 1996-04-25 | 1997-11-11 | Kdk Corp | 被測定成分量の測定方法及び被測定成分量の測定装置 |
| US5997817A (en) * | 1997-12-05 | 1999-12-07 | Roche Diagnostics Corporation | Electrochemical biosensor test strip |
| US6251260B1 (en) * | 1998-08-24 | 2001-06-26 | Therasense, Inc. | Potentiometric sensors for analytic determination |
| US7276146B2 (en) * | 2001-11-16 | 2007-10-02 | Roche Diagnostics Operations, Inc. | Electrodes, methods, apparatuses comprising micro-electrode arrays |
| US20060091006A1 (en) * | 1999-11-04 | 2006-05-04 | Yi Wang | Analyte sensor with insertion monitor, and methods |
| EP2388587B1 (en) | 2000-11-30 | 2018-01-10 | Panasonic Healthcare Holdings Co., Ltd. | Method of quantifying substrate |
| WO2003000127A2 (en) | 2001-06-22 | 2003-01-03 | Cygnus, Inc. | Method for improving the performance of an analyte monitoring system |
| KR100475634B1 (ko) * | 2001-12-24 | 2005-03-15 | 주식회사 아이센스 | 일정 소량의 시료를 빠르게 도입할 수 있는 시료도입부를구비한 바이오 센서 |
| US6863800B2 (en) * | 2002-02-01 | 2005-03-08 | Abbott Laboratories | Electrochemical biosensor strip for analysis of liquid samples |
| ATE507766T1 (de) | 2002-03-22 | 2011-05-15 | Animas Technologies Llc | Leistungsverbesserung einer analytenüberwachungsvorrichtung |
| KR100729307B1 (ko) | 2002-06-17 | 2007-06-15 | 아크레이 인코퍼레이티드 | 글루코스 탈수소효소를 이용한 글루코스 농도 측정방법 및글루코스 센서 |
| JP4341032B2 (ja) * | 2002-11-01 | 2009-10-07 | アークレイ株式会社 | 固体成分濃縮手段を備えた測定用具 |
| MX2008002056A (es) * | 2005-08-16 | 2008-04-19 | Home Diagnostics Inc | Metodo para la fabricacion de una tira de prueba y analisis de una tarjeta de prueba. |
| ES2535657T3 (es) * | 2005-09-14 | 2015-05-13 | Sumitomo Electric Industries, Ltd. | Dispositivo de medición por biosensor, sistema de medición por biosensor, y método de medición por biosensor |
| US7749371B2 (en) * | 2005-09-30 | 2010-07-06 | Lifescan, Inc. | Method and apparatus for rapid electrochemical analysis |
| US20080020452A1 (en) * | 2006-07-18 | 2008-01-24 | Natasha Popovich | Diagnostic strip coding system with conductive layers |
| US7822557B2 (en) | 2006-10-31 | 2010-10-26 | Abbott Diabetes Care Inc. | Analyte sensors and methods |
| US20090007947A1 (en) * | 2006-12-22 | 2009-01-08 | Angela Spangenberg | Portable weather shielding canopy |
| US20090026094A1 (en) * | 2007-05-11 | 2009-01-29 | Home Diagnostics, Inc. | Two-pulse systems and methods for determining analyte concentration |
| TWI453401B (zh) | 2007-07-26 | 2014-09-21 | Nipro Diagnostics Inc | 使用時間解析電流測定法之用於分析物濃度測定的系統及方法（一） |
| US8101062B2 (en) * | 2007-07-26 | 2012-01-24 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
-
2008
- 2008-07-25 TW TW097128393A patent/TWI453401B/zh active
- 2008-07-25 AU AU2008279070A patent/AU2008279070B2/en not_active Expired - Fee Related
- 2008-07-25 MX MX2010000971A patent/MX2010000971A/es active IP Right Grant
- 2008-07-25 WO PCT/US2008/071128 patent/WO2009015316A1/en not_active Ceased
- 2008-07-25 BR BRPI0814201-7A2A patent/BRPI0814201A2/pt active Search and Examination
- 2008-07-25 MX MX2010000972A patent/MX2010000972A/es not_active Application Discontinuation
- 2008-07-25 WO PCT/US2008/071132 patent/WO2009015319A1/en not_active Ceased
- 2008-07-25 JP JP2010518403A patent/JP5179583B2/ja active Active
- 2008-07-25 JP JP2010518401A patent/JP5604298B2/ja active Active
- 2008-07-25 BR BRPI0814202-5A patent/BRPI0814202B1/pt active IP Right Grant
- 2008-07-25 AT AT08796603T patent/ATE523777T1/de not_active IP Right Cessation
- 2008-07-25 TW TW097128397A patent/TW200916774A/zh unknown
- 2008-07-25 US US12/179,870 patent/US20090076738A1/en not_active Abandoned
- 2008-07-25 AU AU2008279067A patent/AU2008279067A1/en not_active Abandoned
- 2008-07-25 EP EP08796603A patent/EP2176653B1/en not_active Not-in-force
- 2008-07-25 EP EP08796601.6A patent/EP2176652B1/en active Active
- 2008-07-25 US US12/179,853 patent/US8088272B2/en active Active
-
2010
- 2010-01-25 MX MX2013002928A patent/MX340856B/es unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6424847B1 (en) * | 1999-02-25 | 2002-07-23 | Medtronic Minimed, Inc. | Glucose monitor calibration methods |
| TW520439B (en) * | 2000-02-02 | 2003-02-11 | Lifescan Inc | Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations |
| CN1311233C (zh) * | 2001-10-26 | 2007-04-18 | 爱科来株式会社 | 特定成份的浓度测定方法和浓度测定装置 |
| US20030096420A1 (en) * | 2001-11-07 | 2003-05-22 | Heller Zindel Herbert | Instrument |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009015319A1 (en) | 2009-01-29 |
| EP2176652A1 (en) | 2010-04-21 |
| TW200916774A (en) | 2009-04-16 |
| US8088272B2 (en) | 2012-01-03 |
| EP2176653A1 (en) | 2010-04-21 |
| BRPI0814201A2 (pt) | 2015-01-27 |
| JP2010534839A (ja) | 2010-11-11 |
| ATE523777T1 (de) | 2011-09-15 |
| MX2010000972A (es) | 2010-03-01 |
| US20090101523A1 (en) | 2009-04-23 |
| BRPI0814202A2 (pt) | 2015-01-27 |
| EP2176653B1 (en) | 2011-09-07 |
| EP2176652B1 (en) | 2014-04-23 |
| AU2008279070B2 (en) | 2012-12-13 |
| US20090076738A1 (en) | 2009-03-19 |
| MX2010000971A (es) | 2010-03-01 |
| AU2008279070A1 (en) | 2009-01-29 |
| WO2009015316A1 (en) | 2009-01-29 |
| AU2008279067A1 (en) | 2009-01-29 |
| JP5604298B2 (ja) | 2014-10-08 |
| TW200914820A (en) | 2009-04-01 |
| MX340856B (es) | 2016-07-28 |
| JP2010534838A (ja) | 2010-11-11 |
| BRPI0814202B1 (pt) | 2019-10-29 |
| JP5179583B2 (ja) | 2013-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI453401B (zh) | 使用時間解析電流測定法之用於分析物濃度測定的系統及方法（一） | |
| AU2010229211B2 (en) | System and methods for determination of analyte concentration using time resolved amperometry | |
| US20120111739A1 (en) | Dual Frequency Impedance Measurement of Hematocrit in Strips | |
| US20090026094A1 (en) | Two-pulse systems and methods for determining analyte concentration | |
| US9347910B2 (en) | Systems and methods for improved stability of electrochemical sensors | |
| KR101723395B1 (ko) | 충전 충분성 방법 및 시스템 | |
| JP2003185615A (ja) | 試料体積の十分性の決定 | |
| WO2008029110A2 (en) | Electrochemical device with 3 detection areas | |
| HK1187985B (en) | System and method for improved stability of electrochemical sensors | |
| HK1187985A (en) | System and method for improved stability of electrochemical sensors | |
| HK1243163B (zh) | 确定分析物浓度的测量装置、生物传感器系统和方法 |